GT Medical Technologies

Tempe, AZ · Founded 2017 · Privately Held (backing)

Developer of a medical therapeutic device designed to overcome the limitations of current treatments by placing it after the tumor removal. GT Medical Technologies is based in Tempe, AZ and was founded in 2017. It was valued at $215 million at its later-stage round in Jun 2025, the last priced event on record. It has raised $161 million across 6 recorded rounds; the latest was a $53.3 million later-stage round in Dec 2024.

PMV mark · valuation
$215.3M
Oct 2026
Priced at
its later-stage round
Jun 2025
Total raised
$161.5M
Last round
Later Stage VC
Dec 2024
What is GT Medical Technologies worth?
$215.3MPrivateMarketView mark · Oct 2026

Valued at $215.3M at its later-stage round, Jun 2025. Nothing has traded since.

Free account
More of GT Medical Technologies with a free account
  • ·The complete investor list: 18 names
  • ·Watch GT Medical Technologies: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

GT Medical Technologies funding history

6 rounds
DateRoundRaisedPost-money
Dec 2024Later Stage VC$53.3M▮
Mar 2023Early Stage VC$37.4M▮
Nov 2020Early Stage VC$15.5M▮
Nov 2018Early Stage VC$5.6M▮
Dec 2017Seed Round$1.9M▮
Dec 2017Debt$510K▮
Unlock post-money valuations

Membership and data by Private Market View

GT Medical Technologies valuation

GT Medical Technologies was valued at $215 million at its later-stage round in Jun 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has GT Medical Technologies raised?

GT Medical Technologies has raised $161 million across 6 recorded rounds since 2017. The largest was a $5.6 million early-stage round in Nov 2018; the most recent was a $53.3 million later-stage round in Dec 2024.

GT Medical Technologies has filed 8 Form Ds with the SEC since 2017, most recently in Jun 2025 ($53.3 million sold to 37 investors).

How GT Medical Technologies's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For GT Medical Technologies, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about GT Medical Technologies

What is GT Medical Technologies worth?
GT Medical Technologies is valued at $215.3M as of Oct 2026. Valued at $215.3M at its later-stage round, Jun 2025. Nothing has traded since.
How much has GT Medical Technologies raised?
GT Medical Technologies has raised $161.5M in total funding across 6 recorded rounds.
When did GT Medical Technologies last raise?
GT Medical Technologies last raised in Dec 2024 (Later Stage VC), raising $53.3M.